脾气虚、肝郁脾虚及胃实热证患者阿魏酸药代动力学特征比较

doi:10.3736/jcim20060208

Abstract

Objective

To investigate the nature of syndrome of traditional Chinese medicine by means of pharmacokinetic (PK) method.

Methods

Twenty-one healthy volunteers, 20 patients with syndrome of stagnation of liver qi and spleen deficiency, 22 patients with syndrome of deficiency of spleen qi and 19 patients with syndrome of excess of stomach heat were included and administered to take Jiawei Xiaoyaosan Recipe (JWXYSR). The serum PK parameters of ferulic acid (FA) were examined by high performance liquid chromatography (HPLC) method.

Results

The absorption rate constant (α) and the elimination rate constant (β) were both decreased while the apparent first-order absorption constant (Ka) was enhanced significantly in the patients with syndrome of deficiency of spleen qi; the α, β and K_a were all reduced in the patients with syndrome of stagnation of liver qi and spleen deficiency; the β and Ka were increased in the patients with syndrome of excess of stomach heat, as compared with the corresponding PK parameters in the healthy volunteers (P＜0.01).

Conclusion

The PK analysis of FA in the patients with syndrome of deficiency of spleen qi shows that the absorption rate is accelerated, and both the distribution and elimination rates are slowed down. The absorption, distribution and elimination rates of AF are all slowed down in the patients with syndrome of stagnation of liver-qi and spleen deficiency, while the absorption and elimination rates of AF are both accelerated in the patients with syndrome of excess of stomach heat. There are obvious differences in the PK characteristics among these three syndromes.

Key words: Syndrome of deficiency of spleen qi, Syndrome of stagnation of liver qi and spleen deficiency, Syndrome of excess of stomach heat, Ferulic acid, Pharm

CLC Number:

R285.6

Ping Ren, Xi Huang, Shuang-qing Li, Shu-yun Xu, Mei-hua Wan, Ya-xiong Zhou, Yi-wu Zhou, Wen-fu Tang. Pharmacokinetic characteristics of ferulic acid in patients with different syndromes of deficiency of spleen qi, stagnation of liver qi and spleen deficiency, and excess of stomach heat. Journal of Chinese Integrative Medicine, 2006, 4(2): 147-151.

/ / Recommend

Add to citation manager EndNote| Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.jcimjournal.com/EN/10.3736/jcim20060208

http://www.jcimjournal.com/EN/Y2006/V4/I2/147

TrendMD

Figures/Tables 4

Figure 1

Figure 2

Table 1

Table 2

References 12

[1]	田中茂. 血中浓度测定法对汉方方剂“证”与疗效决定法的开发[J].国外医学·中医中药分册,1989,10(8):58-59
[2]	.[OTHER]THER].黄熙, 马援, 蒋永培, 等. "证治药动学"假说的科学依据与前景. 见: 陈可冀主编. 迈向21世纪的中西医结合. 北京: 中国医药科技出版社, 1991. 207-216.
[3]	任平, 黄熙."脾"与药动学的关系:理论和实验依据[J].世界华人消化杂志,1999,7(12):1077-1080 doi: 10.3969/j.issn.1009-3079.1999.12.024
[4]	黄熙, 任平, 文爱冬, 等.脾虚大鼠川芎嗪的药物动力学特征与血液流变学研究[J].中国中西医结合杂志,1994,14(3):134, 159-161
[5]	文爱冬, 黄熙, 蒋永培, 等.HPLC法测定血瘀证兔血清中游离阿魏酸[J].药学学报,1995,30(10):762-767
[6]	黄熙, 蒋永培, 臧益民, 等.心血瘀阻犬的川芎嗪药物动力学特征与血流动力学研究[J].中国中西医结合杂志,1996,16(6):352-354 doi: 10.7661/CJIM.1996.6.352
[7]	Jian YP, Wen AD, Huang X, et al.Pharmacokinetics of tetramethylpyrazine phosphate in healthy and blood stasis dogs in vivo[J].Chin J Integr Tradi West Med,1996,2(2):132-134
[8]	任平, 黄熙, 蒋永培, 等.四君子汤对脾虚大鼠胃动素及川芎嗪药物动力学特征的影响[J].中国中西医结合杂志,1997,17(1):45-47
[9]	任平, 黄熙, 张莉, 等.不同脾虚时期大鼠甘草甜素药物动力学特征及其机制的探讨[J].成都中医药大学学报,2000,23(2):30-32 doi: 10.3969/j.issn.1004-0668.2000.02.018
[10]	黄熙, 任平, 杨少文, 等.胃脘痛证型、胃电图与胃镜结果的关系及其用逍遥散治疗的影响[J].陕西中医,1992,13(8):337-339
[11]	周仲瑛. 中医内科学(第1版)[M].北京: 中国中医药出版社,2003,(第1版):
[12]	邓树海, 张秀珍, 邹立家.药物动力学与生物药剂学(第1版)[M].天津: 天津科技翻译出版公司,1992,(第1版):20-38

Related Articles 15

[1]	Tareq A. Wani, Zahoor A. Kaloo, Nisar A. Dangroo. Aconitum heterophyllum Wall. ex Royle: A critically endangered medicinal herb with rich potential for use in medicine. Journal of Integrative Medicine, 2022, 20(2): 104-113.
[2]	Eric Wei Chiang Chan, Siu Kuin Wong, Hung Tuck Chan. An overview on the chemistry, pharmacology and anticancer properties of tetrandrine and fangchinoline (alkaloids) from Stephania tetrandra roots. Journal of Integrative Medicine, 2021, 19(4): 311-316.
[3]	Pukar Khanal, Basanagouda M. Patil. Integration of network and experimental pharmacology to decipher the antidiabetic action of Duranta repens L.. Journal of Integrative Medicine, 2021, 19(1): 66-77.
[4]	Mu-yan Kong, Le-yan Li, Yan-mei Lou, Hong-yu Chi, Jin-jun Wu. Chinese herbal medicines for prevention and treatment of colorectal cancer: from molecular mechanisms to potential clinical applications. Journal of Integrative Medicine, 2020, 18(5): 369-384.
[5]	Zi-jia Zhang, Wen-yong Wu, Jin-jun Hou, Lin-lin Zhang, Fei-fei Li, Lei Gao, Xing-dong Wu, Jing-ying Shi, Rong Zhang, Hua-li Long, Min Lei, Wan-ying Wu, De-an Guo, Kai-xian Chen, Lewis A. Hofmann, Zhonghua Ci. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: network-molecular docking-LC-MS^E analysis. Journal of Integrative Medicine, 2020, 18(3): 229-241.
[6]	Chang-quan Ling. Traditional Chinese medicine is a resource for drug discovery against 2019 novel coronavirus (SARS-CoV-2). Journal of Integrative Medicine, 2020, 18(2): 87-88.
[7]	Deng-hai Zhang, Kun-lun Wu, Xue Zhang, Sheng-qiong Deng, Bin Peng. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of Integrative Medicine, 2020, 18(2): 152-158.
[8]	Rohitash Jamwal. Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers. Journal of Integrative Medicine, 2018, 16(6): 367-374.
[9]	Neeraj K. Sethiya, Nasir M. Ahmed, Raeesh M. Shekh, Vivek Kumar, Pawan Kumar Singh, Vipin Kumar. Ethnomedicinal, phytochemical and pharmacological updates on Hygrophila auriculata (Schum.) Hiene: An overview. Journal of Integrative Medicine, 2018, 16(5): 299-311.
[10]	Zahra Majidi, S.N. Sadati Lamardi. Phytochemistry and biological activities of Heracleum persicum: A review. Journal of Integrative Medicine, 2018, 16(4): 223-235.
[11]	Bikash Manandhar, Keshav Raj Paudel, Biraj Sharma, Rajendra Karki. Phytochemical profile and pharmacological activity of Aegle marmelos Linn.. Journal of Integrative Medicine, 2018, 16(3): 153-163.
[12]	Hoda Mojiri-Forushani, Ali Asghar Hemmati, Mohammad Amin Dehghani, Ali Reza Malayeri, Hossein Hassan Pour. Effects of herbal extracts and compounds and pharmacological agents on pulmonary fibrosis in animal models: A review. Journal of Integrative Medicine, 2017, 15(6): 433-441.
[13]	Rakhi Chakraborty, Swarnendu Roy, Vivekananda Mandal. Assessment of traditional knowledge of the antidiabetic plants of Darjeeling and Sikkim Himalayas in the context of recent phytochemical and pharmacological advances. Journal of Integrative Medicine, 2016, 14(5): 336-358.
[14]	Nisha Panth, Keshav Raj Paudel, Rajendra Karki. Phytochemical profile and biological activity of Juglans regia. Journal of Integrative Medicine, 2016, 14(5): 359-373.
[15]	Jason Yamaki, Kalyan C. Nagulapalli Venkata, Animesh Mandal, Piyali Bhattacharyya, Anupam Bishayee. Health-promoting and disease-preventive potential of Trianthema portulacastrum Linn. (Gadabani)—An Indian medicinal and dietary plant. Journal of Integrative Medicine, 2016, 14(2): 84-99.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2]	Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3]	Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4]	Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5]	A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H₂₂ cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6]	Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7]	Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8]	Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9]	Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10]	Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022

Time after taking	Serum concentration
JWXYSR (min)	Healthy group (n=21)	DSQ group (n=22)	SLQSD group (n=20)	ESH group (n=19)
5	104.38±23.91	26.77±6.61	10.64±1.48	116.38±58.23
10	140.12±30.33	49.70±7.03	22.81±4.86	130.47±63.59
15	152.94±36.11	62.39±6.91	38.49±5.39	109.34±41.67
30	131.76±27.26	76.95±10.39	52.30±8.93	86.39±24.18
60	100.19±22.87	38.00±9.98	33.76±3.28	53.27±16.36
90	95.73±47.39	27.65±6.50	21.58±3.55	29.12±8.41
120	87.29±18.47	16.57±3.29	18.45±5.17	17.78±3.66

Pharmacokinetics parameter	Value
Pharmacokinetics parameter	Healthy group (n=21)	DSQ group (n=22)	SLQSD group (n=20)	ESH group (n=19)
α (min^–1)	0.093±0.022	0.041±0.014**	0.058±0.021**	0.095±0.610
β (min^–1)	0.005 4±0.003 1	0.002 7±0.001 2**	0.003 1±0.010 2**	0.011 0±0.008 1**
K_a (min^–1)	0.38±0.12	0.82±0.12**	0.19±0.01**	0.71±0.02**
t_1/2α (min)	7.63±1.45	19.48±0.78**	13.54±1.95**	7.95±0.88**
t_1/2Ka (min)	19.40±6.80	29.58±8.76**	3.61±1.77**	0.77±6.96**
K₂₁ (min^–1)	0.037±0.001	0.013±0.023**	0.018±0.030**	0.038±0.052
K₁₀(min^–1)	0.019±0.100	0.009 4±0.001**	0.008 1±0.010**	0.021±0.020
K₁₂ (min^–1)	0.044±0.001	0.022±0.001**	0.032±0.001	0.039±0.001
AUC [(μg·L^–1)·min]	20 201.31±1 900.09	16 741.72±7 000.51**	15 570.11±6 350.60**	19 086.31±7 490.81
t_p (min)	12.35±10.40	26.04±0.72**	37.29 ±14.78**	10.74±20.10
C_max(μg·L^–1)	160.98±6.30	78.25±9.45**	57.47±8.59**	136.73±5.83

Pharmacokinetic characteristics of ferulic acid in patients with different syndromes of deficiency of spleen qi, stagnation of liver qi and spleen deficiency, and excess of stomach heat

RichHTML

PDF (PC)

Like